- £29.04m
- £15.38m
- £2.19m
REG - Angle PLC - Contract announcement with Eisai Inc.
AnnouncementRCS - Angle PLC - Parsortix unlocks opportunities for drug discovery
AnnouncementREG - Angle PLC - Broker Announcement
AnnouncementRCS - Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
AnnouncementRCS - Angle PLC - Launch of PD-L1 test to support cancer studies
AnnouncementREG - Angle PLC - Trading and business update
AnnouncementRCS - Angle PLC - Supporting characterisation of CTCs in HNSCC
AnnouncementRCS - Angle PLC - Parsortix outperforms standard for DTC harvest
AnnouncementRCS - Angle PLC - Parsortix system showcased at ACTC conference
AnnouncementREG - Angle PLC - Interim Results for the period ended 30 June 2023
AnnouncementRCS - Angle PLC - ANGLE launch of Portrait Flex assay
AnnouncementREG - Angle PLC - ANGLE notice of interim results
AnnouncementREG - Angle PLC - Result of 2023 Annual General Meeting
AnnouncementREG - Angle PLC - Standard form for notification of major holdings
AnnouncementRCS - Angle PLC - ANGLE announces senior management appointments
AnnouncementREG - Angle PLC - Pharma services contract with Artios Pharma
AnnouncementREG - Angle PLC - Board change - appointment of new Chairman
AnnouncementRCS - Angle PLC - ANGLE presentation via Investor Meet Company
AnnouncementREG - Angle PLC - Results for the year ended 31 December 2022
Announcement